左心室辅助装置植入术中延迟胸骨闭合与一期胸骨闭合对机械循环支持感染的影响
单中心回顾性分析2012年5月至2021年1月首次植入左心室辅助装置(LVAD)的327例患者,比较延迟胸骨闭合(DSC)组127例与一期胸骨闭合(PSC)组200例的术后感染发生率。DSC组中位延迟闭合时间24小时,两组LVAD相关纵隔/胸骨伤口感染、驱动线感染及泵袋感染发生率均无显著差异。
要点
- DSC组与PSC组LVAD相关纵隔/胸骨伤口感染发生率分别为4.7%与3.0%,无显著差异(p=.419)。
- DSC组与PSC组驱动线感染率分别为6.3%与9%,无显著差异(p=.411)。
- DSC组与PSC组泵袋感染率分别为1.6%与1.5%,无显著差异(p=.901)。
核心结论
- 在因凝血功能障碍或血流动力学不稳定而需要延迟胸骨闭合的患者中,DSC似乎不增加LVAD相关或LVAD特异性感染的发生率。
研究设计与样本
- 单中心回顾性分析,纳入2012年5月至2021年1月期间首次接受LVAD植入的患者327例,分为延迟胸骨闭合组(DSC,n=127,39%)和一期胸骨闭合组(PSC,n=200,61%)。
主要发现
- DSC组与PSC组LVAD相关纵隔/胸骨伤口感染发生率分别为4.7%与3.0%,无显著差异(p=.419)。
- DSC组与PSC组驱动线感染发生率分别为6.3%与9%,无显著差异(p=.411)。
- DSC组与PSC组泵袋感染发生率分别为1.6%与1.5%,无显著差异(p=.901)。
- DSC组中位延迟闭合时间为24小时(IQR:24-48)。
- DSC组男性(87% vs 75%,p=.016)、Interagency Registry of Mechanically Assisted Circulatory Support I-II级患者(89% vs 66%,p<.001)、既往胸骨切开史患者(43% vs 13%,p<.001)及慢性肾脏病患者(55% vs 43%,p=.030)比例高于PSC组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Delayed sternal closure may be required after left ventricular assist device (LVAD) implantation due to coagulopathy or hemodynamic instability. There is conflicting data regarding infection risk. METHODS: We performed a single-center, retrospective analysis of patients who received their first LVAD between May 2012 and January 2021. Patients were divided into delayed sternal closure (DSC) and primary sternal closure (PSC) groups. We used chi-squared or Fisher Exact tests, as appropriate, to compare the incidence of postoperative LVAD-related infections (mediastinal/sternal wound) and LVAD-specific infections (driveline and pump pocket) after definitive chest closure between these two groups. RESULTS: A total of 327 patients met eligibility criteria, including 127 (39%) patients that underwent DSC and 200 (61%) patients that had a PSC. Demographic and clinical characteristics were similar except for an overrepresentation of men (87% vs. 75%, p = .016), Interagency Registry of Mechanically Assisted Circulatory Support class I-II patients (89% vs 66%, p < .001), patients with a previous sternotomy (43% vs 13%, p < .001), and patients with chronic kidney disease (55% vs 43%, p = .030) in the DSC group. The median DSC time was 24 (IQR: 24-48) hours. The incidence of LVAD-related mediastinal/sternal wound infection was similar between the DSC and PSC groups (4.7% vs 3.0%, p = .419). There was no difference between DSC and PSC groups in the incidence of driveline infection (6.3% vs 9%, p = .411) and pump pocket infection (1.6% vs 1.5%, p =.901), respectively. CONCLUSIONS: DSC does not seem to increase the incidence of LVAD-related or LVAD-specific infection rates in heart failure patients undergoing device implantation surgery.
引用
- Akay MH, Jezovnik MK, Salas De Armas IA, et al. Delayed versus primary sternal closure for left ventricular assist device implantation: Impact on mechanical circulatory support infections. J Heart Lung Transplant. 2022. PMID: 36641296. doi:10.1016/j.healun.2022.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。